20 genes represented targets related to RAD51 in disease conditions, including ten in ovarian neoplasm, 18 in ovarian carcinoma, one in ovarian adenocarcinoma, and seven in ovarian serous adenocarcinoma. This evidence concerns the gene RAD51 and ovarian neoplasm.